SCHEMBL8312956

SCHEMBL8312956

O=C(c1ccc(Nc2nccc(-c3ccc(S(=O)(=O)c4ccncc4)cc3)n2)cc1)N1CCN(C(=O)c2ccco2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.54
TP53 P04637 1/20 0.54
MTOR P42345 1/20 0.53
SMG1 Q96Q15 1/20 0.53
ALDH1A1 P00352 3/20 0.50
LMNA P02545 3/20 0.50
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CAMK2D Q13557 2/20 0.48
IKBKB O14920 4/20 0.48
CHUK O15111 3/20 0.48
NPSR1 Q6W5P4 1/20 0.48
IKBKG Q9Y6K9 1/20 0.47
ROCK1 Q13464 1/20 0.47
JAK2 O60674 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8314813 0.94 MTOR (0.54) TSHRTP53MTORSMG1ALDH1A1
SCHEMBL14021548 0.88 TSHR (0.54) TSHRTP53ALDH1A1LMNAHTT
SCHEMBL14021335 0.87 MTOR (0.51) TSHRTP53MTORSMG1ALDH1A1
SCHEMBL8311426 0.87 IKBKB (0.56) MTORSMG1CAMK2DIKBKBCHUK
SCHEMBL4071019 0.86 IKBKB (0.56) TSHRIKBKBCHUKJAK2
SCHEMBL14021618 0.86 HTT (0.54) TSHRTP53ALDH1A1LMNAHTT
SCHEMBL14021252 0.86 ALDH1A1 (0.62) TSHRTP53ALDH1A1LMNAHTT
SCHEMBL14020983 0.85 TSHR (0.52) TSHRTP53ALDH1A1LMNAHTT
SCHEMBL14063909 0.85 IKBKB (0.63) MTORSMG1CAMK2DIKBKBCHUK
SCHEMBL8312206 0.85 MTOR (0.50) TSHRTP53MTORSMG1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 WO disclosed